Potential biological functions of cytochrome P450 reductase-dependent enzymes in small intestine: Novel link to expression of major histocompatibility complex class II genes

Journal of Biological Chemistry

Volumn 287, Issue 21, 2012, Pages 17777-17788

  D'Agostino, Jaime ^a   Ding, Xinxin ^a   Zhang, Peng ^a   Jia, Kunzhi ^a   Fang, Cheng ^a   Zhu, Yi ^a   Spink, David C ^a   Zhang, Qing Yu ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; BIOCHEMICAL PROPERTIES; BIOLOGICAL FUNCTIONS; BIOSYNTHETIC ACTIVITIES; CDNA MICROARRAY ANALYSIS; CHOLESTEROL LEVELS; CLASS II; CYTOCHROME P450; DOWNSTREAM TARGET; ENTEROCYTES; FARNESYL PYROPHOSPHATES; GENE ONTOLOGY; GENOMIC CHANGES; HEME OXYGENASES; KNOCK OUTS; LANOSTEROL; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS; MECHANISTIC LINK; MONOOXYGENASES; NADPH-CYTOCHROME P450 REDUCTASE; OXYGENASES; PROTEIN LEVEL; SIGNAL TRANSDUCERS; SMALL INTESTINE; TRANSACTIVATORS; WILD TYPES;

BIOCHEMISTRY; BIOLOGICAL ORGANS; BIOSYNTHESIS; CHOLESTEROL; ENZYMES; GENES; PORPHYRINS; TRANSCRIPTION;

MAMMALS;

BILIRUBIN; CHOLESTEROL; COMPLEMENTARY DNA; DIHYDROLANOSTEROL; FARNESYL DIPHOSPHATE; GERANYLGERANYL PYROPHOSPHATE; HEME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; STAT1 PROTEIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL ISOLATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; INTESTINE CELL; INTESTINE EPITHELIUM; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II GENE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMALL INTESTINE; WILD TYPE;

ANIMALS; BASE SEQUENCE; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTESTINE, SMALL; LANOSTEROL; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; NADPH-FERRIHEMOPROTEIN REDUCTASE; NUCLEAR PROTEINS; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

MUS;

EID: 84861207027     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.354274     Document Type: Article

References (70)

1. Taniguchi, H., Imai, Y., and Sato, R. (1984) Role of electron transfer system in microsomal drug monooxygenase reaction catalyzed by cytochrome P450. Arch. Biochem. Biophys. 232, 585-596 (Pubitemid 14073052)
2. Schacter, B.A., Nelson, E. B., Marver, H. S., and Masters, B. S. (1972) Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J. Biol. Chem. 247, 3601-3607
3. Ono, T., and Bloch, K. (1975) Solubilization and partial characterization of rat liver squalene epoxidase. J. Biol. Chem. 250, 1571-1579
4. Shen, A. L., O'Leary, K. A., and Kasper, C. B. (2002) Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem. 277, 6536-6541 (Pubitemid 34968452)
5. Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., and Miller, W. L. (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat. Genet. 36, 228-230 (Pubitemid 38282745)
6. Gu, J., Weng, Y., Zhang, Q. Y., Cui, H., Behr, M., Wu, L., Yang, W., Zhang, L., and Ding, X. (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene. Impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J. Biol. Chem. 278, 25895-25901 (Pubitemid 36835351)
7. Henderson, C. J., Otto, D. M., Carrie, D., Magnuson, M. A., McLaren, A. W., Rosewell, I., and Wolf, C. R. (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem. 278, 13480-13486 (Pubitemid 36800122)
8. Wu, L., Gu, J., Cui, H., Zhang, Q. Y., Behr, M., Fang, C., Weng, Y., Kluetzman, K., Swiatek, P. J., Yang, W., Kaminsky, L., and Ding, X. (2005) Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene. Effects on development, reproduction, and microsomal cytochrome P450. J. Pharmacol. Exp. Ther. 312, 35-43 (Pubitemid 40096450)
9. Weng, Y., DiRusso, C. C., Reilly, A. A., Black, P. N., and Ding, X. (2005) Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase. J. Biol. Chem. 280, 31686-31698
10. Wang, X. J., Chamberlain, M., Vassieva, O., Henderson, C. J., and Wolf, C. R. (2005) Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice. Biochem. J. 388, 857-867 (Pubitemid 40941573)
11. Zhang, Q. Y., Fang, C., Zhang, J., Dunbar, D., Kaminsky, L., and Ding, X. (2009) An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model. Direct evidence for a role of intestinal P450s in first-pass clearance of oral nifedipine. Drug Metab. Dispos. 37, 651-657
12. Zhu, Y., D'Agostino, J., and Zhang, Q. Y. (2011) Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin. Insights from studies on the intestinal-epithelium-specific P450 reductase knockout mouse. Drug Metab. Dispos. 39, 939-943
13. Fang, C., and Zhang, Q. Y. (2010) The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyrene. J. Pharmacol. Exp. Ther. 334, 156-163
14. Zhang, Q. Y., Dunbar, D., and Kaminsky, L. S. (2003) Characterization of mouse small intestinal cytochrome P450 expression. Drug Metab. Dispos. 31, 1346-1351 (Pubitemid 37310323)
15. Doniger, S. W., Salomonis, N., Dahlquist, K. D., Vranizan, K., Lawlor, S. C., and Conklin, B. R. (2003) MAPPFinder. Using gene ontology and Gen-MAPP to create a global gene expression profile from microarray data. Genome Biol. 4, R7
16. Dahlquist, K. D., Salomonis, N., Vranizan, K., Lawlor, S. C., and Conklin, B. R. (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet. 31, 19-20
17. Folch, J., Lees, M., and Sloane Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509
18. Li, L., and Porter, T. D. (2007) Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase. Arch. Biochem. Biophys. 461, 76-84 (Pubitemid 46627526)
19. Tong, H., Wiemer, A. J., Neighbors, J. D., and Hohl, R. J. (2008) Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue. Anal. Biochem. 378, 138-143
20. Mingone, C. J., Gupte, S. A., Chow, J. L., Ahmad, M., Abraham, N. G., Wolin, M. S. (2006) Protoporphyrin IX generation from δ-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L337-L344 (Pubitemid 44343708)
21. Zelenka, J., Lenicek, M., Muchova, L., Jirsa, M., Kudla, M., Balaz, P., Zadinova, M., Ostrow, J. D., Wong, R. J., and Vitek, L. (2008) Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues. J. Chromatogr. B 867, 37-42
22. D'Agostino, J., Zhang, X., Wu, H., Ling, G., Wang, S., Zhang, Q. Y., Liu, F., and Ding, X. (2008) Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers. Drug Metab. Dispos. 36, 2316-2323
23. Ware, J. A., Graf, M. L., Martin, B. M., Lustberg, L. R., and Pohl, L. R. (1998) Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats. Possible role in allergic reactions. Chem. Res. Toxicol. 11, 164-171 (Pubitemid 28141742)
24. UniProt Consortium (2012) Reorganizing the protein space at the Universal Protein resource (UniProt). Nucleic Acids Res. 40, D71-D75
25. Yee, C. S., Yao, Y., Li, P., Klemsz, M. J., Blum, J. S., and Chang, C. H. (2004) Cathepsin E. A novel target for regulation by class II transactivator. J. Immunol. 172, 5528-5534 (Pubitemid 38542054)
26. Reith, W., LeibundGut-Landmann, S., and Waldburger, J. M. (2005) Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5, 793-806
27. Waldburger, J. M., Suter, T., Fontana, A., Acha-Orbea, H., and Reith, W. (2001) Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J. Exp. Med. 194, 393-406 (Pubitemid 32835036)
28. Bhattacharya, A., Dorf, M. E., and Springer, T. A. (1981) A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions. Evidence for I region gene duplication. J. Immunol. 127, 2488-2495 (Pubitemid 12245847)
29. Schroder, K., Hertzog, P. J., Ravasi, T., and Hume, D. A. (2004) Interferon-γ. An overview of signals, mechanisms, and functions. J. Leukoc. Biol. 75, 163-189 (Pubitemid 38174573)
30. De, S. K., McMaster, M. T., and Andrews, G. K. (1990) Endotoxin induction of murine metallothionein gene expression. J. Biol. Chem. 265, 15267-15274
31. Lukasiak, S., Schiller, C., Oehlschlaeger, P., Schmidtke, G., Krause, P., Legler, D. F., Autschbach, F., Schirmacher, P., Breuhahn, K., and Groettrup, M. (2008) Proinflammatory cytokines cause FAT10 up-regulation in cancers of liver and colon. Oncogene 27, 6068-6074
32. Wang, S., Raven, J. F., and Koromilas, A. E. (2010) STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells. Mol. Cancer Res. 8, 798-805
33. Najjar, I., Schischmanoff, P. O., Baran-Marszak, F., Deglesne, P. A., Youlyouz-Marfak, I., Pampin, M., Feuillard, J., Bornkamm, G. W., Chelbi-Alix, M. K., and Fagard, R. (2008) Novel functions of STAT1β in B cells. Induction of cell death by a mechanism different from that of STAT 1α. J. Leukoc. Biol. 84, 1604-1612 (Pubitemid 352774496)
34. Wen, Z., Zhong, Z., and Darnell, J. E., Jr. (1995) Maximal Activation of Transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250
35. Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., and Zamvil, S. S. (2002) The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420, 78-84 (Pubitemid 35291443)
36. Lee, S. J., Qin, H., and Benveniste, E. N. (2008) The IFN-γ-induced transcriptional program of the CIITA gene is inhibited by statins. Eur. J. Immunol. 38, 2325-2336
37. Goldstein, J. L., and Brown, M. S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430
38. Cheng, C., Noorderloos, M., van Deel, E. D., Tempel, D., den Dekker, W., Wagtmans, K., Duncker, D. J., Soares, M. P., Laman, J. D., and Duckers, H. J. (2010) Dendritic cell function in transplantation arteriosclerosis is regulated by heme oxygenase 1. Circ. Res. 106, 1656-1666
39. Wu, J., Ma, J., Fan, S. T., Schlitt, H. J., and Tsui, T. Y. (2005) Bilirubin derived from heme degradation suppresses MHC class II expression in endothelial cells. Biochem. Biophys. Res. Commun. 338, 890-896 (Pubitemid 41597726)
40. West, A. R., and Oates, P. S. (2008) Mechanisms of heme iron absorption. Current questions and controversies. World J. Gastroenterol. 14, 4101-4110
41. Potten, C. S., and Hendry, J. H. (1983) Stem Cells, Churchill Livingstone, Edinburgh, Scotland
42. Mutch, D. M., Klocke, B., Morrison, P., Murray, C. A., Henderson, C. J., Seifert, M., and Williamson, G. (2007) The disruption of hepatic cytochrome P450 reductase alters mouse lipid metabolism. J. Proteome Res. 6, 3976-3984 (Pubitemid 350032561)
43. Hua, X., Sakai, J., Brown, M. S., and Goldstein, J. L. (1996) Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane. J. Biol. Chem. 271, 10379-10384 (Pubitemid 26132526)
44. Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., and Goldstein, J. L. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. 100, 12027-12032 (Pubitemid 37271509)
45. Chang, T. Y., Chang, C. C., Ohgami, N., and Yamauchi, Y. (2006) Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 22, 129-157
46. Ikonen, E. (2008) Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 125-138
47. Stange, E. F., Suckling, K. E., and Dietschy, J. M. (1983) Synthesis and coenzyme A-dependent esterification of cholesterol in rat intestinal epithelium. Differences in cellular localization and mechanisms of regulation. J. Biol. Chem. 258, 12868-12875 (Pubitemid 14237273)
48. Altmann, S. W., Davis, H. R., Jr., Zhu, L. J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P., Maguire, M., Golovko, A., Zeng, M., Wang, L., Murgolo, N., and Graziano, M. P. (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201-1204 (Pubitemid 38233587)
49. Brufau, G., Groen, A. K., and Kuipers, F. (2011) ATVB in focus: HDL structure, function, therapeutics, and imaging. Reverse cholesterol transport revisited. Contribution of biliary versus intestinal cholesterol excretion. Arterioscler. Thromb. Vasc. Biol. 31, 1726-1733
50. Kalaany, N. Y., and Mangelsdorf, D. J. (2006) LXRs and FXR. The Yin and Yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68, 159-191
51. Ohto, C., Muramatsu, M., Obata, S., Sakuradani, E., and Shimizu, S. (2009) Overexpression of the gene encoding HMG-CoA reductase in Saccharomyces cerevisiae for production of prenyl alcohols. Appl. Microbiol. Bio-technol. 82, 837-845
52. Ohto, C., Muramatsu, M., Obata, S., Sakuradani, E., and Shimizu, S. (2010) Production of geranylgeraniol on overexpression of a prenyl diphosphate synthase fusion gene in Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 87, 1327-1334
53. Keller, R. K. (1996) Squalene synthase inhibition alters metabolism of nonsterols in rat liver. Biochim. Biophys. Acta 1303, 169-179
54. Sadeghi, M. M., Tiglio, A., Sadigh, K., O'Donnell, L., Collinge, M., Pardi, R., and Bender, J. R. (2001) Inhibition of interferon-γ-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation 71, 1262-1268 (Pubitemid 32507145)
55. Ghittoni, R., Napolitani, G., Benati, D., Ulivieri, C., Patrussi, L., Laghi Pasini, F., Lanzavecchia, A., and Baldari, C. T. (2006) Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases. Eur. J. Immunol. 36, 2885-2893 (Pubitemid 44782562)
56. Wang, X., Chowdhury, J. R., and Chowdhury, N. R. (2006) Bilirubin metabolism: Applied physiology. Curr. Paediatr. 16, 70-74 (Pubitemid 43162959)
57. Marinello, A. J., Berrigan, M. J., Struck, R. F., Guengerich, F. P., and Gurtoo, H. L. (1981) Inhibition of NADPH-cytochrome P450 reductase by cyclophosphamide and its metabolites. Biochem. Biophys. Res. Commun. 99, 399-406 (Pubitemid 12195963)
58. Guenthner, T. M., Kahl, G. F., and Nebert, D. W. (1980) NADPH-cytochrome P-450 reductase. Preferential inhibition by ellipticine and other type II compounds having little effect on NADPH-cytochrome c reductase. Biochem. Pharmacol. 29, 89-95 (Pubitemid 10212802)
59. Trakshel, G. M., Kutty, R. K., and Maines, M. D. (1986) Cadmium-mediated inhibition of testicular heme oxygenase activity. The role of NADPH-cytochrome c (P-450) reductase. Arch. Biochem. Biophys. 251, 175-187 (Pubitemid 17192996)
60. Hart, S. N., Wang, S., Nakamoto, K., Wesselman, C., Li, Y., and Zhong, X. B. (2008) Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism. Pharmacogenet. Genomics 18, 11-24 (Pubitemid 351161645)
61. Huang, N., Agrawal, V., Giacomini, K. M., and Miller, W. L. (2008) Genetics of P450 oxidoreductase. Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc. Natl. Acad. Sci. 105, 1733-1738 (Pubitemid 351346583)
62. Gomes, A. M., Winter, S., Klein, K., Turpeinen, M., Schaeffeler, E., Schwab, M., and Zanger, U. M. (2009) Pharmacogenomics of human liver cytochrome P450 oxidoreductase. Multifactorial analysis and impact on microsomal drug oxidation. Pharmacogenomics 10, 579-599
63. Marohnic, C. C., Panda, S. P., McCammon, K., Rueff, J., Masters, B. S., and Kranendonk, M. (2010) Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation. Molecular consequences and rescue of defect. Drug Metab. Dispos. 38, 332-340
64. Karlsson, M., Lundin, S., Dahlgren, U., Kahu, H., Pettersson, I., and Telemo, E. (2001) "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 31, 2892-2900 (Pubitemid 32994540)
65. Van Niel, G., Mallegol, J., Bevilacqua, C., Candalh, C., Brugière, S., Tomaskovic-Crook, E., Heath, J. K., Cerf-Bensussan, N., and Heyman, M. (2003) Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Gut 52, 1690-1697 (Pubitemid 37510387)
66. Mayrhofer, G. (1995) Absorption and presentation of antigens by epithelial cells of the small intestine. Hypotheses and predictions relating to the pathogenesis of coeliac disease. Immunol. Cell Biol. 73, 433-439
67. Brandtzaeg, P., Haraldsen, G., and Rugtveit, J. (1997) Immunopathology of human inflammatory bowel disease. Springer Semin. Immunopathol. 18, 555-589 (Pubitemid 27421337)
68. Appels, N. M., Beijnen, J. H., and Schellens, J. H. (2005) Development of farnesyltransferase inhibitors. A review. Oncologist 10, 565-578
69. Bos, J. L. (1989) Ras oncogenes in human cancers. A review. Cancer Res. 49, 4682-4689
70. Arai, M., Shimizu, S., Imai, Y., Nakatsuru, Y., Oda, H., Oohara, T., and Ishikawa, T. (1997) Mutations of the KI-Ras, P53, and APC genes in adenocarcinomas of the human small intestine. Int. J. Cancer 70, 390-395 (Pubitemid 27107264)